Advances in the Multimodality Management of High-risk Prostate Cancer

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Prostate cancer is a heterogeneous disease with marked variability in its natural progression and response to therapeutic interventions. It is the most commonly diagnosed visceral cancer of men living in western countries, yet it is life-threatening in only a minority of cases. Thus, appropriate patient selection for treatment based on tumor as well as patient characteristics is essential to achieve optimal outcomes. The combination of early cancer detection and technical improvements in local treatment has led to a reduction in disease burden and an increase in cancer survivorship. However, treatment failure remains common among high-risk cases.

Original languageEnglish (US)
Pages (from-to)375-394
Number of pages20
JournalSurgical Oncology Clinics of North America
Issue number2
StatePublished - Apr 2013


  • Adjuvant
  • Androgens
  • Chemotherapy
  • Gleason score
  • Prostate cancer
  • Prostatectomy
  • Radiation

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'Advances in the Multimodality Management of High-risk Prostate Cancer'. Together they form a unique fingerprint.

Cite this